Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma.

Chia-Ling ChangMin-Shu HsiehJin-Yuan ShihYi-Hsuan LeeWei-Yu LiaoChia-Lin HsuChing-Yao YangKuan-Yu ChenJih-Hsiang LeeChao-Chi HoTzu-Hsiu TsaiJames Chih-Hsin YangChong-Jen Yu

Published in: Therapeutic advances in medical oncology (2022)

Although advanced NSCLCsg has a poor survival outcome, our results showed that ICI may prolong OS in patients with advanced NSCLCsg. Further prospective studies are warranted to gain more understanding of the role of ICI in this specific patient population.

Keyphrases

advanced non small cell lung cancer
giant cell
epidermal growth factor receptor
single cell
case report
cell therapy
stem cells
tyrosine kinase
case control
mesenchymal stem cells
weight loss